首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical medicine insights-endocrinology and diabetes

缩写:

ISSN:1179-5514

e-ISSN:1179-5514

IF/分区:3.0/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引256
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Arjun Ballal,Sudha Vidyasagar,Vasudev Acharya et al. Arjun Ballal et al.
Background: Metformin is a widely popular drug to treat type 2 diabetes as it is efficacious, inexpensive and relatively well tolerated with minimal side effect profile. It is known that long term metformin use predispose...
F Guadalupe Peralta-Vera,Enzo Castillo-Céspedes,Lucero Del Carmen Collazos-Huamán et al. F Guadalupe Peralta-Vera et al.
Background: Abdominal obesity (AO) is associated with hyperuricemia (HU) in people with type 2 diabetes (T2DM), but most evidence comes from Asian studies and Latin American data are scarce. This study addresses that gap ...
Domas Grigoravicius,Karolis Laucius,Rasa Ugenskiene et al. Domas Grigoravicius et al.
Iatrogenic Cushing syndrome can occur due to the use of external glucocorticoids. We present a case involving prolonged exposure to glucocorticoids from intramuscular dexamethasone injections, with diagnosis confirmed via abscess fluid anal...
Abigayle B Simon,Dhruti Trivedi,Jeffrey Thomas et al. Abigayle B Simon et al.
Background: Type 1 diabetes (T1D) is an autoimmune disease characterized by insulin deficiency and impaired glucose regulation. While sex hormones are known to influence insulin sensitivity, their specific roles in T1D re...
K Vaishali,Chandana Acharya,Shobha U Kamath et al. K Vaishali et al.
Background: T2DM is a significant contributor to hypoglycemia, mortality, CVD, as well as a leading cause of CKD. Understanding and managing glycosylation discrepancies in T2DM patients with CKD is critical because they a...
Qudsia S Banu,Claudette Donatien,Shannon Ramdeen et al. Qudsia S Banu et al.
Background: The 2025 American Diabetes Association guidelines emphasize the benefits of continuous glucose monitoring (CGM) for patients with diabetes receiving insulin therapy. CGM measures interstitial fluid glucose lev...
Shira Avner,Timothy Robbins Shira Avner
Background: The use of continuous glucose monitoring (CGM) has grown, extending its use to people without diabetes. CGM helps prevent hyperglycaemia-related complications in diabetes, however, its value in people without ...